Alcon Inc. (ALC)
NYSE: ALC · Ophthalmic Goods · Fort Worth, TX · filing with the SEC since 2002
Who owns Alcon Inc.
As filed with the SECHolders of 5% or more
1
Blackrock, Inc. holds 5.9% of Common Stock, as its SCHEDULE 13G/A filed Apr 23, 2025 says.
Directors and officers
0
report now, of 0 people on the record since . Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 23, 2025 · Common Stock
What ALC reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
LumiThera, Inc
A company bought · acquisition · Aug 2025 · owns, named in the 20-F filed Feb 24, 2026
Aurion Biotech, Inc
A company bought · acquisition, subsidiary · Mar 2025 · owns, named in the 20-F filed Feb 24, 2026
Cylite Pty Ltd.
A company bought · acquisition · Jan 2025 · owns, named in the 20-F filed Feb 24, 2026
BELKIN Vision Ltd.
A company bought · acquisition · Sep 2024 · owns, named in the 20-F filed Feb 24, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.